Titre : Protéines de filaments intermédiaires

Protéines de filaments intermédiaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Glycoconjugates
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines de filaments intermédiaires : Questions médicales les plus fréquentes", "headline": "Protéines de filaments intermédiaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines de filaments intermédiaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-03", "dateModified": "2025-02-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines de filaments intermédiaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines du cytosquelette", "url": "https://questionsmedicales.fr/mesh/D003598", "about": { "@type": "MedicalCondition", "name": "Protéines du cytosquelette", "code": { "@type": "MedicalCode", "code": "D003598", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Desmine", "alternateName": "Desmin", "url": "https://questionsmedicales.fr/mesh/D003893", "about": { "@type": "MedicalCondition", "name": "Desmine", "code": { "@type": "MedicalCode", "code": "D003893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.200" } } }, { "@type": "MedicalWebPage", "name": "Protéine gliofibrillaire acide", "alternateName": "Glial Fibrillary Acidic Protein", "url": "https://questionsmedicales.fr/mesh/D005904", "about": { "@type": "MedicalCondition", "name": "Protéine gliofibrillaire acide", "code": { "@type": "MedicalCode", "code": "D005904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.400" } } }, { "@type": "MedicalWebPage", "name": "Kératine-15", "alternateName": "Keratin-15", "url": "https://questionsmedicales.fr/mesh/D053569", "about": { "@type": "MedicalCondition", "name": "Kératine-15", "code": { "@type": "MedicalCode", "code": "D053569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.450.300.500" } } }, { "@type": "MedicalWebPage", "name": "Vimentine", "alternateName": "Vimentin", "url": "https://questionsmedicales.fr/mesh/D014746", "about": { "@type": "MedicalCondition", "name": "Vimentine", "code": { "@type": "MedicalCode", "code": "D014746", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines de filaments intermédiaires", "alternateName": "Intermediate Filament Proteins", "code": { "@type": "MedicalCode", "code": "D007381", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sarah Köster", "url": "https://questionsmedicales.fr/author/Sarah%20K%C3%B6ster", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Sandrine Etienne-Manneville", "url": "https://questionsmedicales.fr/author/Sandrine%20Etienne-Manneville", "affiliation": { "@type": "Organization", "name": "Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr." } }, { "@type": "Person", "name": "Charlotta Lorenz", "url": "https://questionsmedicales.fr/author/Charlotta%20Lorenz", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Anna V Schepers", "url": "https://questionsmedicales.fr/author/Anna%20V%20Schepers", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Rudolf E Leube", "url": "https://questionsmedicales.fr/author/Rudolf%20E%20Leube", "affiliation": { "@type": "Organization", "name": "Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Protecting-group free synthesis of glycoconjugates displaying dual fungicidal and plant defense-eliciting activities.", "datePublished": "2023-09-03", "url": "https://questionsmedicales.fr/article/37690319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bioorg.2023.106829" } }, { "@type": "ScholarlyArticle", "name": "Distinct glycoconjugate cell surface structures make the pelagic diatom Thalassiosira rotula an attractive habitat for bacteria.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36471567", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jpy.13308" } }, { "@type": "ScholarlyArticle", "name": "Catalyst- and Base-free One-pot, Multicomponent, De Novo Assembly of Structurally Diverse Morpholine Glycoconjugates.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36170161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/asia.202200849" } }, { "@type": "ScholarlyArticle", "name": "Ligand-Controlled Stereoselective Synthesis and Biological Activity of 2-Exomethylene Pseudo-glycoconjugates: Discovery of Mincle-Selective Ligands.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37005509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/anie.202302569" } }, { "@type": "ScholarlyArticle", "name": "Sialylation and Sulfation of Anionic Glycoconjugates Are Common in the Extracellular Polymeric Substances of Both Aerobic and Anaerobic Granular Sludges.", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37604486", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.est.2c09586" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines du cytosquelette", "item": "https://questionsmedicales.fr/mesh/D003598" }, { "@type": "ListItem", "position": 5, "name": "Protéines de filaments intermédiaires", "item": "https://questionsmedicales.fr/mesh/D007381" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines de filaments intermédiaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines de filaments intermédiaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Protéines de filaments intermédiaires", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D007381?mesh_terms=Glycoconjugates&page=3#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }

Sources (132 au total)

Sialylation and Sulfation of Anionic Glycoconjugates Are Common in the Extracellular Polymeric Substances of Both Aerobic and Anaerobic Granular Sludges.

Anaerobic and aerobic granular sludge processes are widely applied in wastewater treatment. In these systems, microorganisms grow in dense aggregates due to the production of extracellular polymeric s...

Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors.

The involvement of carbonic anhydrases (CAs) in a myriad of biological events makes the development of new inhibitors of these metalloenzymes a hot topic in current Medicinal Chemistry. In particular,...

Glycoconjugation of Quinoline Derivatives Using the C-6 Position in Sugars as a Strategy for Improving the Selectivity and Cytotoxicity of Functionalized Compounds.

Based on the Warburg effect and the increased demand for glucose by tumor cells, a targeted drug delivery strategy was developed. A series of new glycoconjugates with increased ability to interact wit...

Synthesis of a B-Antigen Hexasaccharide, a B-Lewis b Heptasaccharide and Glycoconjugates Thereof to Investigate Binding Properties of Helicobacter pylori.

Infecting the stomach of almost 50 % of people, Helicobacter pylori is a causative agent of gastritis, peptic ulcers and stomach cancers. Interactions between bacterial membrane-bound lectin, Blood gr...

Adenosine Triphosphate-Responsive Glyconanorods through Self-Assembly of β-Cyclodextrin-Based Glycoconjugates for Targeted and Effective Bacterial Sensing and Killing.

Polymer-based nanomaterials have exhibited promising alternative avenues to combat the globe challenge of multidrug-resistant bacterial infection. However, most of the reported polymeric nanomaterials...